↓ Skip to main content

Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor

Overview of attention for article published in Breast Cancer Research and Treatment, May 1998
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
34 Mendeley
Title
Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor
Published in
Breast Cancer Research and Treatment, May 1998
DOI 10.1023/a:1006052923468
Pubmed ID
Authors

Paul E. Goss

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 15%
Student > Ph. D. Student 4 12%
Student > Master 4 12%
Lecturer 3 9%
Student > Postgraduate 3 9%
Other 3 9%
Unknown 12 35%
Readers by discipline Count As %
Chemistry 6 18%
Medicine and Dentistry 5 15%
Agricultural and Biological Sciences 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Biochemistry, Genetics and Molecular Biology 2 6%
Other 3 9%
Unknown 13 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2009.
All research outputs
#8,517,130
of 25,391,066 outputs
Outputs from Breast Cancer Research and Treatment
#1,843
of 4,981 outputs
Outputs of similar age
#10,779
of 34,113 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#2
of 14 outputs
Altmetric has tracked 25,391,066 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,981 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 34,113 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.